Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Dec;16(4):548-560.
doi: 10.1007/s11938-018-0200-4.

Update on Vaccinating the Patient With Inflammatory Bowel Disease

Affiliations
Review

Update on Vaccinating the Patient With Inflammatory Bowel Disease

Jennifer Coukos et al. Curr Treat Options Gastroenterol. 2018 Dec.

Abstract

Purpose of review: Patients with inflammatory bowel disease (IBD) are at increased risk of infectious diseases independent of their immunosuppression status, and yet, studies suggest that this population is not receiving standard vaccinations at the same rate as the general population. This review seeks to understand why IBD patients may not be receiving recommended immunizations and to provide guidelines on vaccinating this vulnerable population.

Recent findings: Inactive vaccines are recommended for patients with IBD regardless of immunosuppression status due to the increased risk for many vaccine-preventable illnesses. Certain live vaccines can be administered to the immunocompromised patient with IBD. Additionally, many patients with IBD will be immunosuppressed some time in their disease course, further increasing their risk for infection. Despite this understanding, patients with IBD have poor vaccination rates. Inadequate knowledge, limited time with patients, and lack of consensus as to who is responsible for identifying and administering vaccinations are some of the most important barriers to vaccinating the patient with IBD. In this review, we discuss guidelines for vaccinating both the immunocompetent and immunosuppressed patient with IBD as well as provide vaccine-specific recommendations. The evidence suggests that patients with IBD are not receiving recommended vaccinations because of misconceptions on the part of patients as well as a paucity of knowledge by their health care team. Educational programs can be successfully implemented to increase knowledge about appropriate vaccinations and can ultimately increase vaccine uptake among patients with IBD. In the end, gastroenterologists and primary care physicians must work together with their patients with IBD to ensure that recommended vaccinations are administered.

Keywords: HPV; Hepatitis A; Hepatitis B; Immunocompromised; Inflammatory bowel disease; PCV 13; PPSV23; Preventative health; Travel; Vaccination; Varicella; Zoster.

PubMed Disclaimer

References

    1. MMWR Recomm Rep. 2006 Dec 1;55(RR-15):1-48 - PubMed
    1. MMWR Morb Mortal Wkly Rep. 2018 Apr 20;67(15):455-458 - PubMed
    1. MMWR Recomm Rep. 2008 Jun 6;57(RR-5):1-30; quiz CE2-4 - PubMed
    1. Inflamm Bowel Dis. 2011 May;17(5):1117-24 - PubMed
    1. J Crohns Colitis. 2013 May;7(4):301-7 - PubMed

LinkOut - more resources